Multidisciplinary Brain Tumor Clinic

Multidisciplinary Brain Tumor Clinic

  • About
  • Approach
  • Appointments
  • Services
  • Locations
  • Doctors

    • Receiving a diagnosis of a brain tumor can be frightening. The physicians in the Multidisciplinary Brain Tumor Clinic combat this fear with compassion, expertise and cutting-edge research. Together, we work strategically to ensure personalized treatment recommendations that will maximize the benefits for each individual. Whether you’ve received a new diagnosis of cancer or are seeking a second opinion after prior treatment, an appointment at the clinic will allow patients to access the brain tumor expertise and clinical trial options only available at University of Michigan Health.

    Our Approach

    In the multidisciplinary clinic, patients with brain tumors will be seen by expert physicians in the three specialties most crucial for successful treatment: Neurosurgery, Neuro-Oncology, and Radiation Oncology. This will offer your patient a thorough consultation, including immediate access to our Brain Tumor Board discussion and an opportunity to be evaluated for eligibility for any of our clinical trials.

    Learn more about how our research shapes how we treat brain cancer.

    Appointment Information

    To make an appointment at our Multidisciplinary Brain Tumor Clinic please contact: 

    Wendy Schrader, RN
    Brain Tumor Coordinator
    [email protected]
    734-763-7716

    We are also able to provide care and expertise for patients remotely via virtual visits. You may request this option when you call.

    Services

    We are dedicated to caring for a wide range of patients including:

    • Newly diagnosed
    • Previously treated for brain tumors
    • Those who may have recently been discharged from the hospital
    • Those interested in the advanced therapies available only at U-M Health

    Locations
    • Neurosurgery Clinic | Taubman Center 1500 E Medical Center Dr
      Floor 2 Reception G
      Ann Arbor, MI 48109-5338       Get Directions

    Doctors

     Search for a U-M Health doctor     Wajd Nizar Al-Holou, MD

    Wajd Nizar Al-Holou, MD

    Assistant Professor

    Neurological Surgery

    David Bernard Altshuler, MD

    David Bernard Altshuler, MD

    Clinical Assistant Professor

    Neurological Surgery

    Nathan Clarke, MD

    Nathan Clarke, MD

    Clinical Assistant Professor

    Neurology

    Donna Marie Edwards, MD

    Donna Marie Edwards, MD

    Clinical Assistant Professor

    Radiation Oncology

    John Thomas Fortunato, MD

    John Thomas Fortunato, MD

    Clinical Assistant Professor

    Neurology

    Jason Anthony Heth, MD

    Jason Anthony Heth, MD

    Clinical Professor

    Neurological Surgery

    Michelle Miran Kim, MD

    Clinical Associate Professor

    Radiation Oncology

    Denise On-Yee Leung, MD

    Denise On-Yee Leung, MD

    Clinical Associate Professor

    Neurology

    Daniel Richard Wahl, MD

    Daniel Richard Wahl, MD

    Associate Professor

    Radiation Oncology

    Matthew Steven Willsey, MD

    Matthew Steven Willsey, MD

    Assistant Professor

    Neurological Surgery

    News & Stories
    grey image with small white specs next to black image side by side close up
    Health Lab

    Using a microfluidic device to monitor glioblastoma treatment outcomes

    Using a microfluidic device, researchers isolated glioblastoma biomarkers that can be used to predict patient responses to chemotherapy drugs.
         woman in white coat talking in lab with lab glasses on
    Health Lab

    Expanding brain tumor research  

    Maria Castro, Ph.D, of Michigan Medicine, received a prestigious $4.5M NIH grant that will help advance the understanding about deadly tumors and provide a path for developing new treatments.
         light blue background with pink brain with red circle area growing
    Health Lab

    Dietary changes could provide a therapeutic avenue for brain cancer

    A team of researchers from Michigan Medicine tracked how glucose is used in glioblastoma tumor cells. They showed that dietary interventions can slow brain cancer growth in mice.
         brain scan on computer
    Health Lab

    FDA clears new DMG treatment: What it means for a deadly pediatric brain tumor

    Diffuse midline gliomas are aggressive tumors that begin in the brain or spinal cord. It is universally fatal, and patients typically live for nine to 15 months after diagnosis. The FDA has approved ONC201 (dordaviprone) to treat recurrent H3K27M-mutant diffuse glioma. It's the first-ever FDA-approved treatment for this disease.
         doctor talking to patient in clinic in white coat
    Health Lab

    I've been diagnosed with a brain tumor. Now what?

    Facing a brain tumor diagnosis can be an overwhelming experience, but it’s essential to gather information that will help guide the next steps in your care. University of Michigan Health neurosurgeon Wajd Al-Holou, M.D., weighs in on the importance of understanding the diagnosis, exploring various treatment options and seeking the best medical care.
         brain drawing yellow blue
    Health Lab

    Children from disadvantaged communities may die sooner from cancerous brain tumors

    Children with inoperable brain tumors may die sooner if they live in areas with lower average income and education levels, a Michigan Medicine-led study finds.